EU adds six individuals to Annex I chemical-weapons sanctions over Navalny poisoning

EU sanctions-screening and compliance teams must add the six newly listed individuals to denied-party filters and freeze funds and economic resources on any match

Change
On 3 July 2026 the Council of the European Union adopted Implementing Regulation (EU) 2026/1541, adding six individuals — Igor Babkin, Sergey Galan, Irina Derevyagina, Mikhail Gutsalyuk, Olga Yudina and Aleksey Aksyonov, all connected to research on epibatidine linked to Alexei Navalny's death — to Annex I of Regulation (EU) 2018/1542 on restrictive measures against the proliferation and use of chemical weapons, effective on publication and directly applicable in all Member States.
Why it matters
The six named persons are now subject to the asset-freeze and related restrictive measures of Regulation (EU) 2018/1542, directly binding on all EU persons and entities. The listing records each individual's association with the Signal Scientific Centre (SC Signal, INN 7718813855) and its director Artur Aleksandrovich Zhirov, and cites links to GosNIIOKhT, the Military Academy for Radiological, Chemical and Biological Defence, and the Research Institute for Applied Acoustics — relevant for ownership-and-control and associated-entity screening. As an EU Regulation (rather than only the parallel CFSP Decision), it creates immediate, self-executing obligations on financial institutions and firms to screen, freeze and refrain from making funds or economic resources available to the listed persons.
Implications
  • EU financial institutions' sanctions-screening teams must add Igor Babkin, Sergey Galan, Irina Derevyagina, Mikhail Gutsalyuk, Olga Yudina and Aleksey Aksyonov to denied-party filters and freeze any matched funds and economic resources, and refrain from making funds available to them — the Regulation is directly applicable from 3 July 2026 and breach exposes the institution to enforcement under national implementing penalties.
  • Compliance teams must apply ownership-and-control and associated-entity logic to the Signal Scientific Centre (SC Signal, INN 7718813855) and its director Artur Aleksandrovich Zhirov, screening for exposure routed through the listed persons' affiliations even though the entity itself is named as an association rather than a separate listing.
  • Firms in the chemical, defence, research and adjacent sectors, and their trade-finance and export functions, must screen counterparties, contracts and shipments against the six new names and suspend or refuse engagements where a match to a listed person appears — continued performance risks breach of the directly applicable EU restrictive measures.
Who is affected
  • EU financial institutions' sanctions-screening teams
  • Compliance teams applying ownership-and-control screening at EU-regulated entities
  • Chemical, defence, research and trade-finance firms exposed to the listed persons or their affiliations

This is the part most alerts miss — who's affected, what moves first, what to watch. Create a free account to keep your decision trail and get the next relevant change in your inbox.

View on Council of the European Union
Got Questions?

Ask what this change means — grounded in this brief. Source linked for final checks.

Clarify™ · Grounded, not generic

Why not a general AI assistant?

A general assistant will answer almost anything — including beyond what it actually knows, which is where drift and hallucination come from. Ask it the same question twice and you can get two different answers — no good when you need a record you can stand behind.

Clarify™ works differently. It answers only from the specific brief in front of you and its cited primary source. Ask something the brief doesn’t cover and it says so, rather than inventing an answer — and the same question returns a consistent, grounded answer every time. The trade-off is deliberate: narrower, but defensible enough to act on.

Clarify with AI — Pro only

You asked:

Clarify turns any brief into answers specific to your role and exposure.

Pro includes

Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you

$29/month · Founding rate, locked for life. Cancel anytime.

Create a free account to keep clarifying

You asked:

You've used your free guest questions for now. A free account gives you more every month and saves your history — or start a Pro trial for unlimited Clarify and real-time alerts.

Pro includes

Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you

Free account: no card, ever. Pro trial: $29/month after 14 days, no card to start, cancel anytime.

Awareness was never the problem. Translation is.

Your team doesn't miss the change — it loses hours turning a 60-page regulator notice into “what do we actually do.” OwlBrief delivers that as a sourced, decision-ready brief the moment a change publishes.

Get the next brief free →
Similar briefs